Project
Evaluating the impact of biosimilars for Lysosomal Storage Diseases (LSDs) on Sanofi's existing LSD portfolio from a payers' perspective
Summary: Identify how market access for Sanofi's LSDs portfolio might be impacted by a potential entry of biosimilars.
Categories:
Strategy
Client
Location: Cambridge, MA
Industry:
Pharmaceuticals
Type:
For-Profit
Details
Year:
2023-2024
Program:
MMS
Center:
Strategy